INAB

IN8BIO, INC.CIK 1740279 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for INAB PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for INAB

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
FAIRBAIRN EMILY	Director, 10% Owner	13	$0	$0	2026-05-27
Graff Jeremy R.	Director	12	$2.4K	$0	2026-05-09
Rochlin Kate	President and COO	25	$10.0K	$0	2026-05-09
McCall Patrick	Chief Financial Officer	27	$11.0K	$0	2026-05-09
Greenwood Luba	Director	9	$999	$0	2026-05-09
Epperly Corinne	Director	11	$0	$0	2026-05-09
Ho William Tai-Wei	President, CEO and CFO	28	$75.0K	$0	2026-05-09
Lamb Lawrence	EVP and CSO	20	$999	$0	2026-05-09
Brandt Peter C.	Director	25	$200.0K	$0	2026-05-09
Roemer Alan S.	Director	26	$50.0K	$0	2025-12-22
BIOS Fund III NT, LP	10% Owner	3	$0	$0	2025-05-02
Whitfill Travis	Director	6	$0	$0	2024-12-19
BP Directors, LP	10% Owner	4	$0	$0	2024-10-04
BIOS Fund II QP, LP	Director, 10% Owner	10	$103.3K	$0	2024-10-04
Goswami Trishna	Chief Medical Officer	11	$5.0K	$0	2024-09-04
Bios Equity Partners II, LP	Director, 10% Owner	6	$50.5K	$0	2023-12-13
Kreis Leslie W.	Director, 10% Owner	3	$186.0K	$0	2022-12-12
BIOS Fund III QP, LP	Director, 10% Owner	3	$186.0K	$0	2022-12-12
BIOS Fund II NT, LP	Director, 10% Owner	20	$147.0K	$0	2022-09-28
Cavu Advisors, LLC	Director, 10% Owner	6	$103.3K	$0	2022-08-29
Cavu Management, LP	Director, 10% Owner	5	$96.5K	$0	2022-08-17
Transcend Partners Opportunity Fund LLC	10% Owner	8	$2.50M	$0	2022-08-16
BIOS Advisors GP, LLC	Director, 10% Owner	5	$3.37M	$0	2022-08-16
BIOS Fund II, LP	Director, 10% Owner	3	$3.37M	$0	2022-08-16
BIOS Capital Management, LP	10% Owner	14	$0	$0	2021-08-03

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
FAIRBAIRN EMILY	Director	G Gift	2026-05-27	2026-05-29	724,637	—	$0	0	SEC↗
Graff Jeremy R.	Director	A Award deriv	2026-05-09	2026-05-12	22,000	—	$0	22,000	SEC↗
Brandt Peter C.	Director	A Award deriv	2026-05-09	2026-05-12	22,000	—	$0	22,000	SEC↗
Epperly Corinne	Director	A Award deriv	2026-05-09	2026-05-12	22,000	—	$0	22,000	SEC↗
FAIRBAIRN EMILY	Director	A Award deriv	2026-05-09	2026-05-12	22,000	—	$0	22,000	SEC↗
Greenwood Luba	Director	A Award deriv	2026-05-09	2026-05-12	22,000	—	$0	22,000	SEC↗
Ho William Tai-Wei	CEO	A Award deriv	2026-05-09	2026-05-12	154,500	—	$0	154,500	SEC↗
Rochlin Kate	President and COO	A Award deriv	2026-05-09	2026-05-12	60,000	—	$0	60,000	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2026-05-09	2026-05-12	56,250	—	$0	56,250	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2026-05-09	2026-05-12	54,000	—	$0	54,000	SEC↗
Ho William Tai-Wei	CEO	A Award deriv	2026-02-04	2026-02-06	206,000	—	$0	206,000	SEC↗
Rochlin Kate	President and COO	A Award deriv	2026-02-04	2026-02-06	80,000	—	$0	80,000	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2026-02-04	2026-02-06	75,000	—	$0	75,000	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2026-02-04	2026-02-06	72,000	—	$0	72,000	SEC↗
FAIRBAIRN EMILY	Director	A Award	2025-12-22	2025-12-23	724,637	$1.38	$1000.0K	724,637	SEC↗
Brandt Peter C.	Director	A Award	2025-12-22	2025-12-23	72,464	$1.38	$100.0K	95,181	SEC↗
Roemer Alan S.	Director	A Award	2025-12-22	2025-12-23	36,232	$1.38	$50.0K	49,514	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award	2025-12-22	2025-12-23	36,232	$1.38	$50.0K	121,168	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award	2025-12-22	2025-12-23	7,247	$1.38	$10.0K	9,482	SEC↗
Rochlin Kate	Chief Operating Officer	A Award	2025-12-22	2025-12-23	7,247	$1.38	$10.0K	9,085	SEC↗
Roemer Alan S.	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
Brandt Peter C.	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
Epperly Corinne	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
FAIRBAIRN EMILY	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
Graff Jeremy R.	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
Greenwood Luba	Director	A Award deriv	2025-05-08	2025-05-12	63,150	—	$0	63,150	SEC↗
BIOS Fund III NT, LP	10% Owner	J Other deriv	2025-05-02	2025-05-07	574,241	—	$0	0	SEC↗
BIOS Fund III NT, LP	10% Owner	J Other deriv	2025-05-02	2025-05-07	574,241	—	$0	0	SEC↗
BIOS Fund III NT, LP	10% Owner	P Buy deriv	2025-05-02	2025-05-07	1,148,482	—	$0	2,431,763	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2025-05-01	2025-05-07	81,967	$0.18	$14.8K	81,967	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	D To issuer deriv	2025-05-01	2025-05-07	81,967	—	$0	0	SEC↗
Brandt Peter C.	Director	M Exercise deriv	2025-04-30	2025-05-07	81,967	—	$0	0	SEC↗
Brandt Peter C.	Director	M Exercise deriv	2025-04-30	2025-05-07	81,967	—	$0	0	SEC↗
Roemer Alan S.	Director	M Exercise deriv	2025-04-30	2025-05-07	102,459	—	$0	0	SEC↗
Roemer Alan S.	Director	M Exercise deriv	2025-04-30	2025-05-07	11,000	—	$0	0	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	M Exercise deriv	2025-04-30	2025-05-07	15,000	—	$0	0	SEC↗
Rochlin Kate	Chief Operating Officer	M Exercise deriv	2025-04-30	2025-05-07	12,295	—	$0	0	SEC↗
Brandt Peter C.	Director	M Exercise	2025-04-30	2025-05-07	81,967	$0.18	$14.8K	681,538	SEC↗
Brandt Peter C.	Director	M Exercise	2025-04-30	2025-05-07	81,967	$0.18	$14.8K	599,571	SEC↗
Roemer Alan S.	Director	M Exercise	2025-04-30	2025-05-07	102,459	$0.18	$18.4K	387,489	SEC↗
Roemer Alan S.	Director	M Exercise	2025-04-30	2025-05-07	11,000	$0.18	$2.0K	398,489	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	M Exercise	2025-04-30	2025-05-07	15,000	$0.18	$2.7K	67,071	SEC↗
Rochlin Kate	Chief Operating Officer	M Exercise	2025-04-30	2025-05-07	12,295	$0.18	$2.2K	55,169	SEC↗
Brandt Peter C.	Director	D To issuer deriv	2025-04-27	2025-05-07	81,967	—	$0	0	SEC↗
Brandt Peter C.	Director	A Award deriv	2025-04-27	2025-05-07	81,967	—	$0	81,967	SEC↗
Brandt Peter C.	Director	D To issuer deriv	2025-04-27	2025-05-07	81,967	—	$0	0	SEC↗
Brandt Peter C.	Director	A Award deriv	2025-04-27	2025-05-07	81,967	—	$0	81,967	SEC↗
Roemer Alan S.	Director	D To issuer deriv	2025-04-27	2025-05-07	102,459	—	$0	0	SEC↗
Roemer Alan S.	Director	A Award deriv	2025-04-27	2025-05-07	102,459	—	$0	102,459	SEC↗
Roemer Alan S.	Director	D To issuer deriv	2025-04-27	2025-05-07	102,459	—	$0	0	SEC↗
Roemer Alan S.	Director	A Award deriv	2025-04-27	2025-05-07	11,000	—	$0	11,000	SEC↗
Roemer Alan S.	Director	A Award deriv	2025-04-27	2025-05-07	91,459	—	$0	91,459	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	D To issuer deriv	2025-04-27	2025-05-07	15,000	—	$0	5,492	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2025-04-27	2025-05-07	15,000	—	$0	15,000	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	D To issuer deriv	2025-04-27	2025-05-07	20,492	—	$0	0	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2025-04-27	2025-05-07	20,492	—	$0	20,492	SEC↗
Rochlin Kate	Chief Operating Officer	D To issuer deriv	2025-04-27	2025-05-07	12,295	—	$0	0	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2025-04-27	2025-05-07	12,295	—	$0	12,295	SEC↗
Rochlin Kate	Chief Operating Officer	D To issuer deriv	2025-04-27	2025-05-07	12,295	—	$0	0	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2025-04-27	2025-05-07	12,295	—	$0	12,295	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2025-04-27	2025-05-07	81,967	—	$0	81,967	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	D To issuer deriv	2025-04-27	2025-05-07	81,967	—	$0	0	SEC↗
Epperly Corinne	Director	A Award deriv	2025-04-27	2025-05-07	81,967	—	$0	81,967	SEC↗
Epperly Corinne	Director	D To issuer deriv	2025-04-27	2025-05-07	81,967	—	$0	0	SEC↗
Graff Jeremy R.	Director	D To issuer deriv	2025-04-27	2025-05-07	2,049	—	$0	0	SEC↗
Graff Jeremy R.	Director	A Award deriv	2025-04-27	2025-05-07	2,049	—	$0	2,049	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2025-04-27	2025-05-07	1,639	—	$0	1,639	SEC↗
Lamb Lawrence	EVP and CSO	D To issuer deriv	2025-04-27	2025-05-07	1,639	—	$0	0	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2025-02-05	2025-02-07	912,450	—	$0	912,450	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2025-02-05	2025-02-07	338,950	—	$0	338,950	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2025-02-05	2025-02-07	306,750	—	$0	306,750	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2025-02-05	2025-02-07	343,000	—	$0	343,000	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2024-12-19	2024-12-23	1,188,282	—	$0	1,188,282	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2024-12-19	2024-12-23	302,839	—	$0	302,839	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2024-12-19	2024-12-23	286,899	—	$0	286,899	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2024-12-19	2024-12-23	290,085	—	$0	290,085	SEC↗
Roemer Alan S.	Director	A Award deriv	2024-12-19	2024-12-23	93,242	—	$0	93,242	SEC↗
Brandt Peter C.	Director	A Award deriv	2024-12-19	2024-12-23	49,490	—	$0	49,490	SEC↗
Whitfill Travis	Director	A Award deriv	2024-12-19	2024-12-23	42,676	—	$0	42,676	SEC↗
FAIRBAIRN EMILY	Director	A Award deriv	2024-12-19	2024-12-23	31,559	—	$0	31,559	SEC↗
Greenwood Luba	Director	A Award deriv	2024-12-19	2024-12-23	39,449	—	$0	39,449	SEC↗
Graff Jeremy R.	Director	A Award deriv	2024-12-19	2024-12-23	47,697	—	$0	47,697	SEC↗
Epperly Corinne	Director	A Award deriv	2024-12-19	2024-12-23	37,655	—	$0	37,655	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2024-10-04	2024-10-08	126,582	—	$0	126,582	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	D To issuer deriv	2024-10-04	2024-10-08	81,967	—	$0	0	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2024-10-04	2024-10-08	81,967	—	$0	81,967	SEC↗
Brandt Peter C.	Director	A Award deriv	2024-10-04	2024-10-08	81,967	—	$0	81,967	SEC↗
Brandt Peter C.	Director	D To issuer deriv	2024-10-04	2024-10-08	81,967	—	$0	0	SEC↗
Brandt Peter C.	Director	A Award deriv	2024-10-04	2024-10-08	253,164	—	$0	253,164	SEC↗
Roemer Alan S.	Director	A Award deriv	2024-10-04	2024-10-08	126,582	—	$0	126,582	SEC↗
Roemer Alan S.	Director	A Award deriv	2024-10-04	2024-10-08	102,459	—	$0	102,459	SEC↗
Roemer Alan S.	Director	D To issuer deriv	2024-10-04	2024-10-08	102,459	—	$0	0	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2024-10-04	2024-10-08	20,492	—	$0	20,492	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2024-10-04	2024-10-08	25,316	—	$0	25,316	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	D To issuer deriv	2024-10-04	2024-10-08	20,492	—	$0	0	SEC↗
Rochlin Kate	Chief Operating Officer	D To issuer deriv	2024-10-04	2024-10-08	12,295	—	$0	0	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2024-10-04	2024-10-08	12,295	—	$0	12,295	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2024-10-04	2024-10-08	25,316	—	$0	25,316	SEC↗
FAIRBAIRN EMILY	Director	P Buy deriv	2024-10-04	2024-10-08	3,038,743	—	$0	3,038,743	SEC↗
FAIRBAIRN EMILY	Director	P Buy deriv	2024-10-04	2024-10-08	3,038,743	—	$0	3,038,743	SEC↗
BIOS Fund II QP, LP	10% Owner	P Buy deriv	2024-10-04	2024-10-11	709,040	—	$0	1,283,281	SEC↗
BIOS Fund II QP, LP	10% Owner	P Buy deriv	2024-10-04	2024-10-11	709,040	—	$0	709,040	SEC↗
BIOS Fund II QP, LP	10% Owner	A Award deriv	2024-10-04	2024-10-11	574,241	—	$0	574,241	SEC↗
BIOS Fund II QP, LP	10% Owner	D To issuer deriv	2024-10-04	2024-10-11	574,241	—	$0	0	SEC↗
BP Directors, LP	10% Owner	P Buy deriv	2024-10-04	2024-10-11	709,040	—	$0	1,283,281	SEC↗
BP Directors, LP	10% Owner	P Buy deriv	2024-10-04	2024-10-11	709,040	—	$0	709,040	SEC↗
BP Directors, LP	10% Owner	A Award deriv	2024-10-04	2024-10-11	574,241	—	$0	574,241	SEC↗
BP Directors, LP	10% Owner	D To issuer deriv	2024-10-04	2024-10-11	574,241	—	$0	0	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award	2024-10-04	2024-10-08	126,582	—	$0	2,548,094	SEC↗
Brandt Peter C.	Director	A Award	2024-10-04	2024-10-08	253,164	—	$0	517,604	SEC↗
Roemer Alan S.	Director	A Award	2024-10-04	2024-10-08	126,582	—	$0	285,030	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award	2024-10-04	2024-10-08	25,316	—	$0	52,071	SEC↗
Rochlin Kate	Chief Operating Officer	A Award	2024-10-04	2024-10-08	25,316	—	$0	42,874	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2024-09-04	2024-09-05	250,000	—	$0	250,000	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2024-09-04	2024-09-05	500,000	—	$0	500,000	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2024-09-04	2024-09-05	250,000	—	$0	250,000	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2024-09-04	2024-09-05	250,000	—	$0	250,000	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2024-09-04	2024-09-05	250,000	—	$0	250,000	SEC↗
Roemer Alan S.	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
Brandt Peter C.	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
Epperly Corinne	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
FAIRBAIRN EMILY	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
Graff Jeremy R.	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
Greenwood Luba	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
Whitfill Travis	Director	A Award deriv	2024-06-12	2024-06-14	33,650	—	$0	33,650	SEC↗
McCall Patrick	CHIEF FINANCIAL OFFICER	A Award deriv	2024-02-07	2024-02-08	189,000	—	$0	189,000	SEC↗
Lamb Lawrence	EVP AND CSO	A Award deriv	2024-02-07	2024-02-08	169,000	—	$0	169,000	SEC↗
Rochlin Kate	CHIEF OPERATING OFFICER	A Award deriv	2024-02-07	2024-02-08	186,000	—	$0	186,000	SEC↗
Goswami Trishna	CHIEF MEDICAL OFFICER	A Award deriv	2024-02-07	2024-02-08	176,000	—	$0	176,000	SEC↗
Ho William Tai-Wei	PRESIDENT AND CEO	A Award deriv	2024-02-07	2024-02-08	502,000	—	$0	502,000	SEC↗
Epperly Corinne	Director	A Award deriv	2024-02-07	2024-02-08	12,500	—	$0	12,500	SEC↗
Bios Equity Partners II, LP	10% Owner	P Buy deriv	2023-12-13	2023-12-14	574,241	—	$0	574,241	SEC↗
Bios Equity Partners II, LP	10% Owner	P Buy deriv	2023-12-13	2023-12-14	574,241	—	$0	574,241	SEC↗
Bios Equity Partners II, LP	10% Owner	P Buy deriv	2023-12-13	2023-12-14	574,241	—	$0	574,241	SEC↗
Brandt Peter C.	Director	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Brandt Peter C.	Director	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2023-12-13	2023-12-15	1,639	—	$0	1,639	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2023-12-13	2023-12-15	1,639	—	$0	1,639	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2023-12-13	2023-12-15	4,098	—	$0	4,098	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2023-12-13	2023-12-15	4,098	—	$0	4,098	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2023-12-13	2023-12-15	12,295	—	$0	12,295	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2023-12-13	2023-12-15	12,295	—	$0	12,295	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2023-12-13	2023-12-15	20,492	—	$0	20,492	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2023-12-13	2023-12-15	20,492	—	$0	20,492	SEC↗
Ho William Tai-Wei	President and CEO	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Ho William Tai-Wei	President and CEO	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Roemer Alan S.	Director	A Award deriv	2023-12-13	2023-12-15	102,459	—	$0	102,459	SEC↗
Roemer Alan S.	Director	A Award deriv	2023-12-13	2023-12-15	102,459	—	$0	102,459	SEC↗
Epperly Corinne	Director	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Epperly Corinne	Director	A Award deriv	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Graff Jeremy R.	Director	A Award deriv	2023-12-13	2023-12-15	2,049	—	$0	2,049	SEC↗
Graff Jeremy R.	Director	A Award deriv	2023-12-13	2023-12-15	2,049	—	$0	2,049	SEC↗
Brandt Peter C.	Director	A Award	2023-12-13	2023-12-15	81,967	—	$0	264,440	SEC↗
Lamb Lawrence	EVP and CSO	A Award	2023-12-13	2023-12-15	1,639	—	$0	101,369	SEC↗
Goswami Trishna	Chief Medical Officer	A Award	2023-12-13	2023-12-15	4,098	—	$0	6,729	SEC↗
Rochlin Kate	Chief Operating Officer	A Award	2023-12-13	2023-12-15	12,295	—	$0	17,558	SEC↗
McCall Patrick	Chief Financial Officer	A Award	2023-12-13	2023-12-15	20,492	—	$0	26,755	SEC↗
Ho William Tai-Wei	President and CEO	A Award	2023-12-13	2023-12-15	81,967	—	$0	2,421,512	SEC↗
Roemer Alan S.	Director	A Award	2023-12-13	2023-12-15	102,459	—	$0	158,448	SEC↗
Epperly Corinne	Director	A Award	2023-12-13	2023-12-15	81,967	—	$0	81,967	SEC↗
Graff Jeremy R.	Director	A Award	2023-12-13	2023-12-15	2,049	—	$0	4,549	SEC↗
Epperly Corinne	Director	A Award deriv	2023-12-06	2023-12-08	54,800	—	$0	54,800	SEC↗
Graff Jeremy R.	Director	P Buy	2023-09-13	2023-09-15	2,500	$0.95	$2.4K	2,500	SEC↗
McCall Patrick	Chief Financial Officer	P Buy	2023-08-25	2023-08-28	1,000	$1.03	$1.0K	6,263	SEC↗
Ho William Tai-Wei	President and CEO	P Buy	2023-08-24	2023-08-28	23,800	$1.05	$25.0K	2,339,545	SEC↗
FAIRBAIRN EMILY	Director	J Other	2023-07-28	2023-08-01	4,111,958	—	$0	0	SEC↗
Ho William Tai-Wei	President and CEO	A Award deriv	2023-06-21	2023-06-23	393,950	—	$0	393,950	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2023-06-21	2023-06-23	77,600	—	$0	77,600	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2023-06-21	2023-06-23	67,800	—	$0	67,800	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2023-06-21	2023-06-23	87,150	—	$0	87,150	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2023-06-21	2023-06-23	134,000	—	$0	134,000	SEC↗
Roemer Alan S.	Director	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
Graff Jeremy R.	Director	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
Greenwood Luba	Director	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
Whitfill Travis	Director	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
FAIRBAIRN EMILY	Director, 10% Owner	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
Brandt Peter C.	Director	A Award deriv	2023-06-15	2023-06-16	85,000	—	$0	85,000	SEC↗
Graff Jeremy R.	Director	A Award deriv	2023-05-01	2023-05-03	27,000	—	$0	27,000	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2023-04-14	2023-04-18	200,000	—	$0	200,000	SEC↗
Ho William Tai-Wei	President and CEO	A Award deriv	2023-04-14	2023-04-18	393,950	—	$0	393,950	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2023-04-14	2023-04-18	200,000	—	$0	200,000	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2023-04-14	2023-04-18	200,000	—	$0	200,000	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2023-04-14	2023-04-18	200,000	—	$0	200,000	SEC↗
Ho William Tai-Wei	President and CEO	A Award deriv	2023-04-14	2023-06-23	393,950	—	$0	393,950	SEC↗
BIOS Fund III QP, LP	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	8,735	$2.48	$21.7K	570,724	SEC↗
BIOS Fund III QP, LP	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	9,214	$2.48	$22.9K	601,980	SEC↗
BIOS Fund III QP, LP	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	57,052	$2.48	$141.5K	3,727,597	SEC↗
Kreis Leslie W.	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	8,735	$2.48	$21.7K	570,724	SEC↗
Kreis Leslie W.	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	9,214	$2.48	$22.9K	601,980	SEC↗
Kreis Leslie W.	Director, 10% Owner	P Buy	2022-12-12	2022-12-13	57,052	$2.48	$141.5K	3,727,597	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2022-10-21	2022-10-25	68,427	—	$0	68,427	SEC↗
Ho William Tai-Wei	President, CEO and CFO	A Award deriv	2022-10-21	2022-10-25	83,265	—	$0	83,265	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2022-10-21	2022-10-25	62,826	—	$0	62,826	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2022-10-21	2022-10-25	60,555	—	$0	60,555	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2022-10-21	2022-10-25	59,796	—	$0	59,796	SEC↗
Bios Equity Partners II, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	2,913	$2.02	$5.9K	561,989	SEC↗
Bios Equity Partners II, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	19,017	$2.02	$38.4K	3,670,545	SEC↗
Bios Equity Partners II, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	3,070	$2.02	$6.2K	592,766	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	2,913	$2.02	$5.9K	561,989	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	19,017	$2.02	$38.4K	3,670,545	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-09-28	2022-09-29	3,070	$2.02	$6.2K	592,766	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	4,660	$2.02	$9.4K	559,076	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	4,912	$2.02	$9.9K	589,696	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	30,428	$2.02	$61.5K	3,651,528	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	4,660	$2.02	$9.4K	559,076	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	4,912	$2.02	$9.9K	589,696	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-29	2022-08-30	30,428	$2.02	$61.5K	3,651,528	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	1,377	$2.01	$2.8K	584,784	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	8,531	$2.01	$17.1K	3,621,100	SEC↗
Cavu Advisors, LLC	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	1,306	$2.01	$2.6K	554,416	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	1,377	$2.01	$2.8K	584,784	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	8,531	$2.01	$17.1K	3,621,100	SEC↗
BIOS Fund II QP, LP	Director, 10% Owner	P Buy	2022-08-26	2022-08-30	1,306	$2.01	$2.6K	554,416	SEC↗
Cavu Management, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	38,035	$1.93	$73.4K	3,612,569	SEC↗
Cavu Management, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	5,823	$1.93	$11.2K	553,110	SEC↗
Cavu Management, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	6,142	$1.93	$11.9K	583,407	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	5,823	$1.93	$11.2K	553,110	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	38,035	$1.93	$73.4K	3,612,569	SEC↗
BIOS Fund II NT, LP	Director, 10% Owner	P Buy	2022-08-17	2022-08-18	6,142	$1.93	$11.9K	583,407	SEC↗
BIOS Advisors GP, LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	206,575	$1.90	$392.5K	540,287	SEC↗
BIOS Advisors GP, LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	217,891	$1.90	$414.0K	217,891	SEC↗
BIOS Advisors GP, LLC	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	1,349,218	$1.90	$2.56M	3,574,534	SEC↗
BIOS Fund II, LP	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	206,575	$1.90	$392.5K	540,287	SEC↗
BIOS Fund II, LP	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	1,349,218	$1.90	$2.56M	3,574,534	SEC↗
BIOS Fund II, LP	Director, 10% Owner	P Buy	2022-08-16	2022-08-17	217,891	$1.90	$414.0K	217,891	SEC↗
Brandt Peter C.	Director	P Buy	2022-08-16	2022-08-18	105,263	$1.90	$200.0K	182,473	SEC↗
Roemer Alan S.	Director	P Buy	2022-08-16	2022-08-18	26,315	$1.90	$50.0K	55,989	SEC↗
Greenwood Luba	Director	P Buy	2022-08-16	2022-08-18	526	$1.90	$999	7,826	SEC↗
Lamb Lawrence	EVP and CSO	P Buy	2022-08-16	2022-08-18	526	$1.90	$999	99,730	SEC↗
Goswami Trishna	Chief Medical Officer	P Buy	2022-08-16	2022-08-18	2,631	$1.90	$5.0K	2,631	SEC↗
McCall Patrick	Chief Financial Officer	P Buy	2022-08-16	2022-08-18	5,263	$1.90	$10.0K	5,263	SEC↗
Rochlin Kate	Chief Operating Officer	P Buy	2022-08-16	2022-08-18	5,263	$1.90	$10.0K	5,263	SEC↗
Ho William Tai-Wei	President, CEO and CFO	P Buy	2022-08-16	2022-08-18	26,315	$1.90	$50.0K	2,315,745	SEC↗
Transcend Partners Opportunity	10% Owner	P Buy	2022-08-16	2022-08-18	789,473	$1.90	$1.50M	4,111,958	SEC↗
Brandt Peter C.	Director	A Award deriv	2022-06-01	2022-09-23	13,500	—	$0	13,500	SEC↗
FAIRBAIRN EMILY	Director, 10% Owner	A Award deriv	2022-06-01	2022-09-23	13,500	—	$0	13,500	SEC↗
Greenwood Luba	Director	A Award deriv	2022-06-01	2022-09-23	13,500	—	$0	13,500	SEC↗
Roemer Alan S.	Director	A Award deriv	2022-06-01	2022-09-23	13,500	—	$0	13,500	SEC↗
Whitfill Travis	Director	A Award deriv	2022-06-01	2022-09-23	13,500	—	$0	13,500	SEC↗
Whitfill Travis	Director	A Award deriv	2022-06-01	2022-06-14	10,500	—	$0	10,500	SEC↗
Roemer Alan S.	Director	A Award deriv	2022-06-01	2022-06-14	10,500	—	$0	10,500	SEC↗
Greenwood Luba	Director	A Award deriv	2022-06-01	2022-06-14	10,500	—	$0	10,500	SEC↗
FAIRBAIRN EMILY	Director, 10% Owner	A Award deriv	2022-06-01	2022-06-14	10,500	—	$0	10,500	SEC↗
Brandt Peter C.	Director	A Award deriv	2022-06-01	2022-06-14	10,500	—	$0	10,500	SEC↗
Lamb Lawrence	EVP and CSO	M Exercise deriv	2022-05-05	2022-05-09	26,204	—	$0	1,171	SEC↗
Lamb Lawrence	EVP and CSO	M Exercise	2022-05-05	2022-05-09	26,204	$1.07	$28.0K	99,204	SEC↗
Ho William Tai-Wei	President, CEO and CFO	A Award deriv	2022-02-15	2022-02-17	254,500	—	$0	254,500	SEC↗
Rochlin Kate	Chief Operating Officer	A Award deriv	2022-02-15	2022-02-17	96,000	—	$0	96,000	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2022-02-15	2022-02-17	62,500	—	$0	62,500	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2022-02-15	2022-02-17	90,500	—	$0	90,500	SEC↗
McCall Patrick	Chief Financial Officer	A Award deriv	2022-02-15	2022-02-17	84,500	—	$0	84,500	SEC↗
Goswami Trishna	Chief Medical Officer	A Award deriv	2021-11-19	2021-11-23	250,000	—	$0	250,000	SEC↗
Roemer Alan S.	Director	A Award deriv	2021-11-19	2021-11-23	86,258	—	$0	86,258	SEC↗
Cavu Management, LP	10% Owner	J Other deriv	2021-08-13	2021-08-17	10,500	—	$0	10,500	SEC↗
Cavu Management, LP	10% Owner	J Other deriv	2021-08-13	2021-08-17	12,775	—	$0	12,775	SEC↗
BIOS Advisors GP, LLC	10% Owner	J Other deriv	2021-08-13	2021-08-17	10,500	—	$0	10,500	SEC↗
BIOS Advisors GP, LLC	10% Owner	J Other deriv	2021-08-13	2021-08-17	12,775	—	$0	12,775	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	75,588	—	$0	0	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	25,195	—	$0	0	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	2,930,332	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	309,823	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	907,007	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	1,706,490	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	522,355	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	2,023,568	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	326,795	—	$0	0	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	228,438	—	$0	0	SEC↗
Ho William Tai-Wei	President, CEO and CFO	C Conversion deriv	2021-08-03	2021-08-03	2,792	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	1,706,490	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	228,438	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	907,007	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	309,823	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	2,023,568	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	326,795	—	$0	0	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion deriv	2021-08-03	2021-08-03	522,355	—	$0	0	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2021-08-03	2021-08-03	22,082	—	$0	83,582	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion	2021-08-03	2021-08-03	27,706	—	$0	27,706	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion	2021-08-03	2021-08-03	83,124	—	$0	91,336	SEC↗
Transcend Partners Opportunity	10% Owner	C Conversion	2021-08-03	2021-08-03	3,222,485	—	$0	3,222,485	SEC↗
Transcend Partners Opportunity	10% Owner	P Buy	2021-08-03	2021-08-03	100,000	$10.00	$1.00M	3,322,485	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	359,374	—	$0	359,374	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	2,225,316	—	$0	2,225,316	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	1,876,624	—	$0	1,876,624	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	251,211	—	$0	251,211	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	997,433	—	$0	997,433	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	340,712	—	$0	340,712	SEC↗
BIOS Capital Management, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	574,432	—	$0	574,432	SEC↗
Ho William Tai-Wei	President, CEO and CFO	C Conversion	2021-08-03	2021-08-03	3,070	—	$0	72,999	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	1,876,624	—	$0	1,876,624	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	359,374	—	$0	359,374	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	251,211	—	$0	251,211	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	997,433	—	$0	997,433	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	340,712	—	$0	340,712	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	2,225,316	—	$0	2,225,316	SEC↗
BIOS Fund II NT, LP	10% Owner	C Conversion	2021-08-03	2021-08-03	574,432	—	$0	574,432	SEC↗
Brandt Peter C.	Director	A Award deriv	2021-07-29	2021-08-02	10,500	—	$0	10,500	SEC↗
FAIRBAIRN EMILY	Director, 10% Owner	A Award deriv	2021-07-29	2021-08-02	21,000	—	$0	21,000	SEC↗
Greenwood Luba	Director	A Award deriv	2021-07-29	2021-08-02	21,000	—	$0	21,000	SEC↗
Ho William Tai-Wei	President, CEO and CFO	A Award deriv	2021-07-29	2021-08-02	220,500	—	$0	220,500	SEC↗
Lamb Lawrence	EVP and CSO	A Award deriv	2021-07-29	2021-08-02	61,500	—	$0	61,500	SEC↗